胃肠道间质瘤转移灶切除术。
Metastasectomy for gastrointestinal stromal tumors.
机构信息
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
出版信息
J Surg Oncol. 2014 Jan;109(1):23-7. doi: 10.1002/jso.23451. Epub 2013 Oct 24.
Abstract
Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the intestinal tract. Improvements in understanding the molecular pathogenesis of GIST have resulted in novel treatment strategies combining surgery with tyrosine kinase inhibitors (TKIs). Metastasectomy in carefully selected patients who have stable or responsive disease on imatinib should be considered in the multidisciplinary setting. We review existing data on surgical cytoreduction in metastatic GIST while on targeted therapy and compare outcomes with either treatment alone.
摘要
胃肠道间质瘤（GIST）是最常见的肠道肉瘤。对 GIST 分子发病机制的认识的提高，导致了将手术与酪氨酸激酶抑制剂（TKIs）相结合的新的治疗策略。对于在伊马替尼治疗下疾病稳定或有反应的精心选择的患者，应考虑在多学科环境下进行转移灶切除术。我们回顾了靶向治疗时转移性 GIST 手术减瘤的现有数据，并将其与单独治疗的结果进行了比较。
相似文献
1
Metastasectomy for gastrointestinal stromal tumors.胃肠道间质瘤转移灶切除术。
J Surg Oncol. 2014 Jan;109(1):23-7. doi: 10.1002/jso.23451. Epub 2013 Oct 24.
2
Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors.优化手术和伊马替尼治疗胃肠道间质瘤。
J Gastrointest Surg. 2013 Nov;17(11):1997-2006. doi: 10.1007/s11605-013-2243-0. Epub 2013 Jun 18.
3
Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.手术在伊马替尼治疗后复发或转移的胃肠道间质瘤患者中的作用：中国的一项前瞻性随机试验。
Eur J Cancer. 2014 Jul;50(10):1772-1778. doi: 10.1016/j.ejca.2014.03.280. Epub 2014 Apr 22.
4
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).伊马替尼时代行转移灶切除术的 GIST 患者的长期随访——预后因素分析（EORTC-STBSG 合作研究）。
Eur J Surg Oncol. 2014 Apr;40(4):412-9. doi: 10.1016/j.ejso.2013.12.020. Epub 2014 Jan 15.
5
Unusual presentation of gastrointestinal stromal tumor with early cerebral involvement.胃肠道间质瘤伴早期颅内侵犯的不典型表现。
Ir J Med Sci. 2011 Sep;180(3):765-6. doi: 10.1007/s11845-010-0591-2. Epub 2010 Sep 30.
6
Surgical Management of Metastatic Gastrointestinal Stromal Tumors.胃肠道间质瘤的外科治疗。
Curr Treat Options Oncol. 2021 Mar 20;22(5):37. doi: 10.1007/s11864-021-00837-0.
7
[Treatment progress of gastrointestinal stromal tumor].[胃肠道间质瘤的治疗进展]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):292-6.
8
Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.手术与分子联合治疗：胃肠道间质瘤模型
Ann Surg. 2006 Aug;244(2):176-84. doi: 10.1097/01.sla.0000218080.94145.cf.
9
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.酪氨酸激酶抑制剂治疗转移性胃肠道间质瘤的细胞减灭术：2 家机构的分析。
Ann Surg. 2018 Aug;268(2):296-302. doi: 10.1097/SLA.0000000000002281.
10
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.十二指肠胃肠道间质瘤：从临床病理特征到手术结果
Eur J Surg Oncol. 2015 Jul;41(7):814-22. doi: 10.1016/j.ejso.2015.04.004. Epub 2015 Apr 24.
引用本文的文献
1
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.基于指南的胃肠道间质瘤低复发风险患者的随访结局：意大利肉瘤组报告。
JAMA Netw Open. 2023 Nov 1;6(11):e2341522. doi: 10.1001/jamanetworkopen.2023.41522.
2
Surgical Management of Gastrointestinal Stromal Tumors.胃肠道间质瘤的外科治疗
J Adv Pract Oncol. 2023 Sep;14(6):541-547. doi: 10.6004/jadpro.2023.14.6.7. Epub 2023 Sep 1.
3
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors.胃肠道间质瘤转移患者的十年生存情况。
Ann Surg Oncol. 2022 Oct;29(11):7123-7132. doi: 10.1245/s10434-022-12063-5. Epub 2022 Jul 12.
4
Gastrointestinal stromal tumor metastasis to the ovary: A case report.胃肠道间质瘤转移至卵巢：一例报告。
SAGE Open Med Case Rep. 2021 Apr 29;9:2050313X211012511. doi: 10.1177/2050313X211012511. eCollection 2021.
5
Surgical Management of Metastatic Gastrointestinal Stromal Tumors.胃肠道间质瘤的外科治疗。
Curr Treat Options Oncol. 2021 Mar 20;22(5):37. doi: 10.1007/s11864-021-00837-0.
6
Case report: multiple gastrointestinal stroma tumors in the background of neurofibromatosis type 1.病例报告：1型神经纤维瘤病背景下的多发胃肠道间质瘤。
J Surg Case Rep. 2020 Dec 24;2020(12):rjaa516. doi: 10.1093/jscr/rjaa516. eCollection 2020 Dec.
7
Primary Tumor Resection Improves Survival in Patients With Metastatic Gastrointestinal Stromal Tumors: A Preliminary Population-Based Analysis.原发性肿瘤切除可提高转移性胃肠道间质瘤患者的生存率：一项基于人群的初步分析。
Front Oncol. 2020 Aug 19;10:1440. doi: 10.3389/fonc.2020.01440. eCollection 2020.
8
Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries.对海湾地区和黎凡特国家胃肠道肿瘤挑战的全面综述。
World J Clin Cases. 2020 Feb 6;8(3):487-503. doi: 10.12998/wjcc.v8.i3.487.
9
Gastrointestinal stromal tumors: A multidisciplinary challenge.胃肠道间质瘤：多学科的挑战。
World J Gastroenterol. 2018 May 14;24(18):1925-1941. doi: 10.3748/wjg.v24.i18.1925.
10
Recent advances in managing gastrointestinal stromal tumor.胃肠道间质瘤治疗的最新进展
F1000Res. 2017 Sep 14;6:1689. doi: 10.12688/f1000research.11118.1. eCollection 2017.
本文引用的文献
1
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132.胃肠间质瘤新辅助/辅助伊马替尼治疗Ⅱ期临床试验：放射治疗肿瘤学组 0132 长期随访结果
Ann Surg Oncol. 2012 Apr;19(4):1074-80. doi: 10.1245/s10434-011-2190-5. Epub 2011 Dec 28.
2
Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison.腹腔镜与开腹胃切除术治疗原发性胃肠道间质瘤（GIST）：一项大小匹配的比较。
Ann Surg Oncol. 2011 Jun;18(6):1599-605. doi: 10.1245/s10434-010-1517-y. Epub 2011 Jan 5.
3
Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors.胃肠间质瘤肝转移切除联合伊马替尼治疗。
Surg Today. 2010 Oct;40(10):936-42. doi: 10.1007/s00595-009-4171-x. Epub 2010 Sep 25.
4
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.NCCN 工作组报告：胃肠道间质瘤患者管理的最新进展。
J Natl Compr Canc Netw. 2010 Apr;8 Suppl 2(0 2):S1-41; quiz S42-4. doi: 10.6004/jnccn.2010.0116.
5
Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate.舒尼替尼治疗转移性胃肠道间质瘤患者的细胞减灭术。
Ann Surg Oncol. 2010 Feb;17(2):407-15. doi: 10.1245/s10434-009-0784-y. Epub 2009 Nov 7.
6
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.局部原发性胃肠间质瘤切除术后辅助使用甲磺酸伊马替尼：一项随机、双盲、安慰剂对照试验。
Lancet. 2009 Mar 28;373(9669):1097-104. doi: 10.1016/S0140-6736(09)60500-6. Epub 2009 Mar 18.
7
Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).胃肠道间质瘤（GIST）肝转移的诊断与多学科管理
Eur J Surg Oncol. 2009 Aug;35(8):787-92. doi: 10.1016/j.ejso.2009.01.003. Epub 2009 Jan 29.
8
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.原发性和继发性激酶基因型与舒尼替尼在伊马替尼耐药胃肠道间质瘤中的生物学和临床活性相关。
J Clin Oncol. 2008 Nov 20;26(33):5352-9. doi: 10.1200/JCO.2007.15.7461. Epub 2008 Oct 27.
9
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.北美协作组甲磺酸伊马替尼治疗晚期胃肠道间质瘤的III期试验中激酶基因型与临床结局的相关性：癌症与白血病B组及西南肿瘤协作组的CALGB 150105研究
J Clin Oncol. 2008 Nov 20;26(33):5360-7. doi: 10.1200/JCO.2008.17.4284. Epub 2008 Oct 27.
10
Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).晚期胃肠道间质瘤（GISTs）患者接受伊马替尼治疗后的手术干预。
J Surg Oncol. 2008 Jul 1;98(1):27-33. doi: 10.1002/jso.21065.
Zotero 插件